Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat
- PMID: 2087255
- DOI: 10.1016/0028-3908(90)90110-d
Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat
Abstract
The pharmacological characterisation and topographical distribution of [3H]-(S)-zacopride recognition sites in the forebrain of the rat was studied using homogenate and autoradiographic radioligand binding techniques. [3H]-(S)-Zacopride labelled a single, saturable, specific binding site (defined by 10.0 microM granisetron) in homogenates prepared from the entorhinal cortex of the rat (pKD = 9.51 +/- 0.08; Bmax = 104 +/- 7 fmol mg-1 protein; mean +/- SEM, n = 8). Pharmacological characterisation of the recognition site, within the entorhinal cortex, suggested that [3H]-(S)-zacopride selectively labelled the recognition site of the 5-HT3 receptor. Specific binding of [3H]-(S)-zacopride (defined by 1.0 microM granisetron) was differentially distributed throughout the forebrain of the rat; highest densities were located within sub-nuclei of the amygdala (cortical amygdaloid nucleus, amygdalohippocampal area, posterior medial cortical amygdaloid nucleus, posterior lateral amygdaloid nucleus), cortical areas (primary olfactory cortex, entorhinal cortex) and hippocampus. Non-specific binding was distributed homogeneously, although lower in myelinated structures. It is concluded that [3H]-(S)-zacopride selectively labels 5-HT3 receptor recognition sites within the forebrain of the rat; the topographical distribution of these sites, within the limbic nuclei, is consistent with the behavioural actions in animal models of the selective 5-HT3 receptor antagonists.
Similar articles
-
Autoradiographic distribution of [3H]-(S)-zacopride-labelled 5-HT3 receptors in human brain.J Neurol Sci. 1996 Dec;144(1-2):119-27. doi: 10.1016/s0022-510x(96)00211-0. J Neurol Sci. 1996. PMID: 8994113
-
Labelling of 5-HT3 receptor recognition sites in the rat brain using the agonist radioligand [3H]meta-chlorophenylbiguanide.Eur J Pharmacol. 1993 Oct 12;243(1):13-8. doi: 10.1016/0014-2999(93)90161-a. Eur J Pharmacol. 1993. PMID: 8253120
-
Distribution of S(-)-zacopride-insensitive [125I]R(+)-zacopride binding sites in the rat brain and peripheral tissues.Eur J Pharmacol. 1997 Aug 13;332(3):307-12. doi: 10.1016/s0014-2999(97)01091-1. Eur J Pharmacol. 1997. PMID: 9300265
-
The psychopharmacology of 5-HT3 receptors.Pharmacol Ther. 1990;47(2):181-202. doi: 10.1016/0163-7258(90)90086-h. Pharmacol Ther. 1990. PMID: 2203069 Review.
-
The central 5-HT3 receptor in CNS disorders.Neurochem Res. 1998 May;23(5):653-9. doi: 10.1023/a:1022486705184. Neurochem Res. 1998. PMID: 9566603 Review.
Cited by
-
Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal.Psychopharmacology (Berl). 1991;105(3):322-8. doi: 10.1007/BF02244425. Psychopharmacology (Berl). 1991. PMID: 1839177
-
Effect of the 5-HT3 receptor antagonists, MDL72222 and ondansetron on morphine place conditioning.Psychopharmacology (Berl). 1992;106(3):315-20. doi: 10.1007/BF02245411. Psychopharmacology (Berl). 1992. PMID: 1533288
-
Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment.CNS Drugs. 2004;18(15):1105-18. doi: 10.2165/00023210-200418150-00005. CNS Drugs. 2004. PMID: 15581381 Review.
-
Serotonergic modulation of Neural activities in the entorhinal cortex.Int J Physiol Pathophysiol Pharmacol. 2012;4(4):201-10. Epub 2012 Dec 26. Int J Physiol Pathophysiol Pharmacol. 2012. PMID: 23320133 Free PMC article.
-
Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride.Br J Pharmacol. 1992 Sep;107(1):233-9. doi: 10.1111/j.1476-5381.1992.tb14492.x. Br J Pharmacol. 1992. PMID: 1384906 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources